Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)

NCT01266668

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Chonbuk National University Hospital Jeonju, South Korea

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

NCT00003874

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +40 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan

NCT01479387

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Many Locations, Japan

View Trial Details

Completed

Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma

NCT00113841

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen

NCT01478269

Conditions: B-Cell Lymphomas, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Hemocentro-Unicamp Campinas, Brazil

Centro Medico Santa Isabel, Brazil

Centro Paulista de Oncologia São Paulo, Brazil

Santa Casa Medical School São Paulo, Brazil

View all 39 locations

View Trial Details

Completed

HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma

NCT00144092

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

View Trial Details

Completed

Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma

NCT00003195

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007

NCT01470924

Conditions: Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +13 more
Locations: Orebro University Hospital Örebro, Örebro County, Sweden

View Trial Details

Completed

Prevention of Methotrexate Induced Nephrotoxicity and Prolonged Drug Elimination Time With 12 Hours Prehydration

NCT00570817

Conditions: Ependymoma, Glioma, Hematologic Diseases, +20 more
Locations: Aarhus University Hospital, Skejby Aarhus, Aarhus N, Denmark

View Trial Details

Completed

Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia

NCT00078234

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +24 more
Locations: Georgetown University Medical Center/Lombardi Cancer Center Washington D.C., District of Columbia, United States

Roswell Park Cancer Institute Buffalo, New York, United States

Long Island Jewish Medical Center New Hyde Park, New York, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions